InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-24.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Murphy Polly A., 董事. Officer active across 2 companies, notably Atea Pharmaceuticals, Inc.. Cumulatively, 6 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €139k. Activity tracked since 20 December 2021. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Murphy Polly A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
29,600 股Common StockSEC:0001193125-26-279718:0
1,530 股0Common StockSEC:0001829248-26-000002:0
29,600 股0Common StockSEC:0000950170-25-089607:0
33,150 股0Common StockSEC:0000950170-24-074989:0
5,000 股@ US$9.6766100.0% 占其流量Common StockSEC:0001062993-22-022722:0
标准退出：2023年2月20日 (T+90)
12,000 股@ US$8.5663100.0% 占其流量Common StockSEC:0000899243-21-049313:0
标准退出：2022年3月20日 (T+90)
6 条申报中的 6 条
About Murphy Polly A.
Murphy Polly A. is Administrateur and a director at Atea Pharmaceuticals, Inc. and Celcuity Inc. The record shows 6 filings in total, and the 6 sampled filings run from 2021-12-21 to 2026-06-23. Over this sampled period, buys amount to EUR 138649, sells to EUR 0, and the dominant transaction nature is Levée d'options.
